Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
暂无分享,去创建一个
A. Crisci | S. Gelmini | M. Pazzagli | C. Orlando | C. Selli | B. Salvadori
[1] B. Liu,et al. Telomerase in human bladder cancer. , 2000, The Urologic clinics of North America.
[2] K. Ohyashiki,et al. Subsequential telomerase activity in exfoliated urinary cells detects recurrent disease in bladder cancer after transurethral resection. , 1999, International journal of oncology.
[3] B. Liu,et al. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. , 1999, Urology.
[4] N. Oakley. Urinary cytology and competitive reverse transcriptase polymerase chain reaction analysis of a specific CD44 variant to detect and monitor bladder cancer , 1999 .
[5] M. Rahat,et al. Telomerase activity in patients with transitional cell carcinoma , 1999, Cancer.
[6] D J O'Kane,et al. Comparison of screening methods in the detection of bladder cancer. , 1999, The Journal of urology.
[7] K. Ohyashiki,et al. A combination of semiquantative telomerase assay and in‐cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia , 1998, Cancer.
[8] S. Kyo,et al. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] S. Kagawa,et al. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma. , 1998, British journal of urology.
[10] S. Capaccioli,et al. Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. , 1998, Clinical chemistry.
[11] M. Droller,et al. Urinary telomerase and its possible role as a marker for bladder cancer. , 1998, The Keio journal of medicine.
[12] J. Shay,et al. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] F. Carballo,et al. Detection of H-ras mutations in urine sediments by a mutant-enriched PCR technique. , 1998, Clinical chemistry.
[14] K. Yamaguchi,et al. Diagnosis of bladder cancer by analysis of the allelic loss of the p53 gene in urine samples using blunt-end single-strand conformation polymorphism. , 1998, International journal of cancer.
[15] S. C. Yang,et al. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] M. Droller,et al. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity , 1998, Cancer.
[17] W. Murphy,et al. The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms. , 1997, The Journal of urology.
[18] C. Cordon-Cardo,et al. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[19] O. Yoshida,et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. , 1997, Journal of the National Cancer Institute.
[20] A. Gazdar,et al. Telomerase and early detection of cancer: a National Cancer Institute workshop. , 1997, Journal of the National Cancer Institute.
[21] R. Dahse,et al. Telomeres and telomerase: biological and clinical importance. , 1997, Clinical chemistry.
[22] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[23] N. Kim,et al. Clinical implications of telomerase in cancer. , 1997, European journal of cancer.
[24] J. Double,et al. Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. , 1997, British Journal of Cancer.
[25] Kazuhiro Yoshida,et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine , 1997, Cancer.
[26] F. Ishikawa,et al. A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. , 1996, Oncogene.
[27] José Costa,et al. PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR , 1996, Nucleic Acids Res..
[28] M. Mandal,et al. Cell cycle-dependent modulation of telomerase activity in tumor cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Hosaka,et al. Telomerase activity in human bladder cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] K. Collins,et al. Structure and function of telomerase. , 1996, Current opinion in cell biology.
[31] G. Morin. Is telomerase a universal cancer target? , 1995, Journal of the National Cancer Institute.
[32] A. Gazdar,et al. Telomerase activity in small-cell and non-small-cell lung cancers. , 1995, Journal of the National Cancer Institute.
[33] M. S. Rhyu. Telomeres, telomerase, and immortality. , 1995, Journal of the National Cancer Institute.
[34] Keiko Hiyama,et al. Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.
[35] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[36] S. Raab,et al. Low grade transitional cell carcinoma of the bladder. Cytologic Diagnosis by Key Features as Identified by Logistic Regression Analysis , 1994, Cancer.
[37] E. Blackburn. Telomeres: No end in sight , 1994, Cell.
[38] E. Blackburn,et al. Structure and function of telomeres , 1991, Nature.
[39] L. S. Cram,et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[40] G. Murphy,et al. Evaluation of biological markers in bladder cancer. , 1975, The Journal of urology.
[41] G. Arnaldi,et al. Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas. , 2000, The Journal of clinical endocrinology and metabolism.
[42] J. Campbell. Financing the Ideal Long-Term Care System Through Social Insurance , 1999 .
[43] H. Stein,et al. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. , 1998, The Journal of pathology.